REVERSIR™ compounds
US12241064B2 · kind B2 · utility
0Cited by
6References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Aug 10, 2021 |
| Grant date | Mar 4, 2025 |
| Priority date | — |
| Expiry date | Aug 10, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC12N2320/53
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention relates, in general to agents that modulate the pharmacological activity of conjugated siRNAs.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.